Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

1910.ai Model Foundry review

#18 of 30 in AI Drug Discovery Software

A cloud discovery suite linking multi-omics, molecule design and lab assays.

6.5/10Editor score
1910.ai Model Foundry6.5 Contact 1910

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

1910.ai Model Foundry is part of 1910’s ITO drug-discovery platform for biotech and pharmaceutical partners. It brings biological and computational data together with AI/ML workflows for target identification and small- and large-molecule design. The product is aimed at mid-market and enterprise teams that need discovery work to connect computational analysis with experimental feedback, rather than a standalone molecule-design tool.

Its scope spans the discovery pipeline: teams can prepare multimodal data through formatting, cleaning, annotation, curation and featurization, then evaluate, select, sample, train and run models. Target identification draws on multi-omic patient-derived tissue and clinical data. For molecule design, the platform suggests synthetic routes and considers feasibility, yield and scale-up. Model observability, provenance, alignment and safety features address oversight of model outputs; federated learning is intended to let partners learn across datasets without sharing private datasets. Robotics-driven wet-lab assays add a route to candidate testing, making the suite most relevant where computational and lab workflows need to inform one another.

The platform is cloud-based and lists Microsoft Azure, Microsoft Azure Quantum Elements and NVIDIA among its integrations. Commercial access is described through partnering models, with contact-sales pricing; direct Platform-as-a-Service access to software modules is in development. That makes the offering a better fit for organizations prepared to engage through a partnership than for teams seeking immediate self-service software access or published plan choices. Choose Model Foundry if you need a broad discovery suite spanning data preparation, modeling, molecule design and lab assays. A team focused only on repurposing or looking for a standalone, directly accessible application may be better served by a narrower alternative.

1910.ai Model Foundry pros and cons

  • Where it wins
    • Identifies targets from multi-omic patient tissue and clinical data
    • Designs small and large molecules with synthetic-route suggestions
    • Connects federated learning with robotics-driven wet-lab assays
  • Where it doesn't
    • Access is through commercial partnering models
    • Direct Platform-as-a-Service access is still in development
    • Designed for biotech and pharmaceutical partners, not broad self-service use

1910.ai Model Foundry fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update